Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Cash from Operations (2016 - 2025)

Sonoma Pharmaceuticals has reported Cash from Operations over the past 16 years, most recently at 764000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations fell 235.22% year-over-year to 764000.0; the TTM value through Dec 2025 reached 3509000.0, down 2306.92%, while the annual FY2025 figure was 88000.0, 96.33% up from the prior year.
  • Cash from Operations for Q4 2025 was 764000.0 at Sonoma Pharmaceuticals, down from 635000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 565000.0 in Q4 2024 and troughed at 2441000.0 in Q1 2023.
  • A 5-year average of 888800.0 and a median of 1008000.0 in 2023 define the central range for Cash from Operations.
  • On a YoY basis, Cash from Operations climbed as much as 151.18% in 2024 and fell as far as 324.19% in 2024.
  • Year by year, Cash from Operations stood at 326000.0 in 2021, then decreased by 6.75% to 348000.0 in 2022, then crashed by 217.24% to 1104000.0 in 2023, then surged by 151.18% to 565000.0 in 2024, then plummeted by 235.22% to 764000.0 in 2025.
  • Business Quant data shows Cash from Operations for SNOA at 764000.0 in Q4 2025, 635000.0 in Q3 2025, and 2015000.0 in Q2 2025.